Nicox(法國(guó))

Nicox

法國(guó)Nicoxwww.nicox.com法國(guó)生物技術(shù)公司NicoxNicOxisapharmaceuticalcompanyfocusedontheresearch,developmentandfuturecommercializationofdrugcandidates.NicOxisapplyingitsproprietarynitricoxide-donatingR&Dplatfor mtodevelopaninternalportfolioofNewMolecularEntities(NMEs)forthepotentialtreatmentofinflammatory,cardiometabolicandophthalmologicaldiseases.Resourcesarefocusedonthedevelopmentandpre-commercializationactivitiesfornaproxcinod,aproprietaryNMEandthefirst-in-classCyclooxygenase-InhibitingNitricOxide-Donating(CINOD)anti-inflammatoryagentdevelopedforthereliefofsignsandsymptomsofosteoarthritis.Naproxcinodiscurrentlyunderreviewbyregulatoryauthorities,followingthesubmissionandfilingofaNewDrugApplication(NDA)totheUSFoodandDrugAdministration(FDA)andaMarketingAuthorizationApplication(MAA)totheEuropeanMedicinesAgency(EMA).TheFDAplanstoholdameeting